Amiodarone

Atrial fibrillation is a common cardiac rhythm disturbance and increases in prevalence with advancing age. Approximately 1% of patients with...


Before initiating antiarrhythmic drug therapy, treatment of precipitating or reversible causes of atrial fibrillation is recommended. ( Class I; Level...


Despite endorsement of Digoxin in clinical practice guidelines, there exist limited data on its safety in atrial fibrillation / atrial...


Little is known in clinical practice about antiarrhythmic drugs ( AADs ) use in patients with atrial fibrillation ( particularly...


The efficacy and safety of anticoagulation with use of vitamin K antagonists ( VKAs ) is highly dependent on the...


Health professionals are advised that the Product Information for Quetiapine has been updated to include additional information regarding risks of...


Dronedarone ( Multaq ) is an Amiodarone analog that differs structurally from Amiodarone in that the iodine moiety was removed...


Pharmacological rhythm control ( often including electrical or pharmacological cardioversion ) is an integral part of therapy for atrial fibrillation...


In the EU ( European Union ), Zydelig ( Idelalisib ) is indicated in combination with Rituximab ( MabThera )...


The American Association for Thoracic Surgery ( AATS ) has released new evidence-based guidelines for the prevention and treatment of...


Pradaxa is a medicine that contains the active substance Dabigatran etexilate; it is used to prevent the formation of blood...


Edoxaban ( Lixiana ), an oral direct factor Xa inhibitor, is in development for thromboprophylaxis, including prevention of stroke and...


Peripartum cardiomyopathy is an uncommon disorder associated with pregnancy in which the heart dilates and weakens, leading to symptoms of...


Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation recurs frequently after restoration of normal sinus rhythm. Antiarrhythmic drugs...


The FDA ( Food and Drug Administration ) has informed the public that it has revised the dose limitation for...


Pfizer has informed Healthcare Professional of updated prescribing advice for Atorvastatin ( Lipitor ). The new advice relates to interactions...


Pfizer has informed Healthcare Professional of updated prescribing advice for Atorvastatin ( Lipitor ). The new advice relates to interactions...


Acorda Therapeutics anf FDA ( Food and Drug Administration ) have informed that concomitant use of Tizanidine ( Zanaflex )...


Use of the antiarrhythmic agent Amiodarone ( Cordarone ) is associated with one-half the incidence of atrial tachyarrhythmias following cardiac...


Use of Amiodarone ( Cordarone ), an antiarrhythmic drug, in combination with a beta-blocker is effective in preventing shocks...